Najib Roger Accar

Make This Breast Cancer Awareness Month About More Than Awareness with Accarent Health

Retrieved on: 
Tuesday, October 24, 2023
Physician, Keck, USC, Najib Roger Accar, Health, Diagnosis, Partnership, Radiation, Breast cancer, Cancer, Patient, Breast, Social, Dentistry, MD

Awareness and screening are essential, but what comes next for those facing a breast cancer diagnosis?

Key Points: 
  • Awareness and screening are essential, but what comes next for those facing a breast cancer diagnosis?
  • For those with a suspicion of cancer, Accarent’s Cancer Diagnosis Confirmation and Recommended Treatment Plan can be very beneficial.
  • Over 70% of patients will undergo some type of surgery to treat their breast cancer.
  • Surgery may be done to remove as much of the cancer as possible, explore whether the cancer has spread, or restore the appearance of the breast.

Increase Access to Life Saving Cancer Treatment with Accarent Health’s Oncology and Gene Therapy Bundles

Retrieved on: 
Tuesday, October 24, 2023
American Cancer Society, Survival, FDA, CAR, Food, Bone marrow, Najib Roger Accar, Certification, Death, Institute for Clinical and Economic Review, Disease, Transport, Partnership, Cancer, Hospital, Patient, Diagnosis, Food and Drug Administration Safety and Innovation Act, Pharmaceutical industry, MD

CAR T-Cell therapy is a specific kind of gene therapy being used to treat cancer.

Key Points: 
  • CAR T-Cell therapy is a specific kind of gene therapy being used to treat cancer.
  • Currently, six CAR T-cell therapies have been approved by the Food and Drug Administration (FDA) for the treatment of blood cancers.
  • Accarent Health, a unified technology and care management platform granting access to pre-negotiated, fixed bundled prices for complex medical procedures and treatments, offers a variety of cancer treatment bundles eliminating unpredictable costs and providing increased access to quality care.
  • For more information or to access these or other behavioral health treatment options visit Accarent Health at www.accarenthealth.com.

Accarent Health's Commitment: Ensuring Equal Access to Premium Cardiovascular Care

Retrieved on: 
Thursday, October 19, 2023
Angiography, Angioplasty, Najib Roger Accar, Certification, Percutaneous coronary intervention, Transport, Myocardial infarction, Risk, Hypertension, Aortic stenosis, Hospital, National Institute for Health and Care Excellence, Patient, Death, Cardiac catheterization, Pharmaceutical industry, Nursing, MD, Health

They also are less likely than non-minority patients to receive potentially beneficial treatments such as angiography or percutaneous coronary intervention.

Key Points: 
  • They also are less likely than non-minority patients to receive potentially beneficial treatments such as angiography or percutaneous coronary intervention.
  • In addition to improved awareness and better control of hypertension in minority populations, improved access to appropriate intervention is important to addressing these disparities.
  • Accarent Health is a unified technology and care management platform granting access to pre-negotiated, fixed bundled prices for complex medical procedures and treatments, eliminating unpredictable costs and providing increased access to quality care.
  • For more information or to access these or other cardiovascular treatment options visit Accarent Health at www.accarenthealth.com.

Increase Access to Life Saving Cancer Treatment with Accarent Health’s Oncology and Gene Therapy Bundles

Retrieved on: 
Wednesday, September 6, 2023
Partnership, Survival, Bone marrow, Cancer, Certification, CAR, Death, Food and Drug Administration Safety and Innovation Act, Hospital, Patient, Institute for Clinical and Economic Review, Diagnosis, American Cancer Society, Transport, FDA, Food, Disease, Najib Roger Accar, Pharmaceutical industry, MD

CAR T-Cell therapy is a specific kind of gene therapy being used to treat cancer.

Key Points: 
  • CAR T-Cell therapy is a specific kind of gene therapy being used to treat cancer.
  • Currently, six CAR T-cell therapies have been approved by the Food and Drug Administration (FDA) for the treatment of blood cancers.
  • Accarent Health, a unified technology and care management platform granting access to pre-negotiated, fixed bundled prices for complex medical procedures and treatments, offers a variety of cancer treatment bundles eliminating unpredictable costs and providing increased access to quality care.
  • For more information or to access these or other behavioral health treatment options visit Accarent Health at www.accarenthealth.com.

Accarent Health Partners with One of the Mid-Atlantic Region’s Most Dynamic Health Systems

Retrieved on: 
Monday, April 3, 2023
Heart, Taiwan Excellence Awards, Society, Travel, American College of Cardiology, Hospital, Health, Healthgrades, U.S. News & World Report, Cardiothoracic surgery, ChristianaCare, Patient, Cardiology, Case management, Growth, American College, News, Najib Roger Accar, Nursing, Health insurance, Newsweek, MD

“With the addition of ChristianaCare, Accarent continues the growth and development of our high-quality network,” said Tim Koch, President of Accarent Health.

Key Points: 
  • “With the addition of ChristianaCare, Accarent continues the growth and development of our high-quality network,” said Tim Koch, President of Accarent Health.
  • With a focus on improving outcomes, making high-quality care more accessible and lowering health care costs, ChristianaCare is shaping the future of health care.
  • Accarent Health connects employers, patients, and plan administrators to a network of top-rated medical centers for superior, cost-effective care.
  • Employers interested in adopting a value-based health care system can learn more about Accarent Health at www.accarenthealth.com.